# Ixekizumab Diabetes Intervention Trial (I-DIT)

> **NCT04589325** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Göteborg University** · enrollment: 127 (estimated)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** Ixekizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04589325
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-09
- **Primary completion:** 2027-02
- **Final completion:** 2027-12
- **Target enrollment:** 127 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04589325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04589325, "Ixekizumab Diabetes Intervention Trial (I-DIT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04589325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*